{"id":5758,"date":"2020-11-04T20:42:17","date_gmt":"2020-11-04T20:42:17","guid":{"rendered":"http:\/\/hnetalk.com\/provider\/?p=5758"},"modified":"2020-11-04T21:32:08","modified_gmt":"2020-11-04T21:32:08","slug":"clinical-review-criteria-november-2020","status":"publish","type":"post","link":"http:\/\/hnetalk.com\/provider\/clinical-review-criteria-november-2020\/","title":{"rendered":"Clinical Review Criteria &#8211; November 2020"},"content":{"rendered":"<p>Health New England\u2019s Clinical Policies have been updated and can be found at <a href=\"http:\/\/healthnewengland.org\/providers\/resources\" target=\"_blank\" rel=\"noopener\">healthnewengland.org\/Providers\/Resources<\/a>. Once on the Resources page, click on Behavioral Health\/Medical Policies to learn of the changes.<\/p>\n<p><strong>New Medical Policies (Effective 12\/1\/2020)<\/strong><br \/>\nAzedra (iobenguane I 131)<br \/>\nNodify Lung Nodule Risk Assessment BDX-XL2 (Biodesix, Inc.)<\/p>\n<p><strong>New Medical Policy (Effective 1\/1\/2021)<\/strong><br \/>\nDeep Brain Stimulation Treatment for Essential Tremor and Parkinson\u2019s Disease<\/p>\n<p><strong>Reviewed and Updated (Effective 12\/1\/2020<\/strong><br \/>\nTreatment of Lipodystrophy Syndrome (LDS)<br \/>\n\u2022 Updated Criteria for Approval &#8211; Added \u201cCommercial, Medicare, Medicaid\u201d to the section title<br \/>\n\u2022 HCPC Codes &#8211; Deleted Code C9800<br \/>\n\u2022 CPT Codes &#8211; Deleted Codes 15878 and 15879, as policy is for facial lipodystrophy<\/p>\n<p><strong>Surgical Management of Morbid Obesity<\/strong><br \/>\n\u2022 Updated Criteria for Approval:<br \/>\no Criteria for Approval for Ages 18 and Over<br \/>\no Criteria for Approval for Adolescents Ages 13-17<br \/>\no Repeat Bariatric Surgery<br \/>\no Medicare<br \/>\n\u2022 What is Not Covered<\/p>\n<p><strong>Contact Lenses<\/strong><br \/>\n\u2022 Updated Definitions, Scleral Shell or Shield &#8211; Added \u201cIt functions as a protective barrier against tear evaporation. Used as an artificial support and a protective covering for diseased eye or sightless or shrunken eye.\u201d<br \/>\n\u2022 Updated Criteria for Approval<\/p>\n<p><strong>Cochlear Implants, BAHA (Bone Anchored Hearing Aid), and ABI (Auditory Brainstem Implant)<\/strong><br \/>\n\u2022 Changed name of policy to add ABI<br \/>\n\u2022 Updated Definitions: Added description of hybrid cochlear implant<br \/>\n\u2022 Added HNE adopted InterQual criteria (where applicable)<br \/>\n\u2022 Updated headings in several sections:<br \/>\nFrom: \u201cAdult Criteria for Approval of Cochlear Implant for Commercial\/MassHealth\u201d<br \/>\nTo: \u201cCriteria for Approval of Cochlear Implant for All Lines of Business\u201d<\/p>\n<p>From: \u201cIV., Criteria for Approval of Hybrid Cochlear Implant\/Hearing Aid Devices that include hearing aid integration into the external sound processor of the cochlear implant when all of the\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 below criteria are met:\u201d<br \/>\nTo: \u201cII., Criteria for Approval of Hybrid Cochlear Implant\/Hearing Aid Devices (such as the Nuclear Hybrid L24 Cochlear Implant System) that include hearing aid integration into the external<br \/>\nsound processor of the cochlear implant when all the below criteria are met:\u201d<\/p>\n<p>Health New England\u2019s Clinical Policies have been updated and can be found at <a href=\"http:\/\/healthnewengland.org\/Providers\/Resources\" target=\"_blank\" rel=\"noopener\">healthnewengland.org\/Providers\/Resources<\/a>. Once on the Resources page, click on Behavioral Health\/Medical Policies to learn of the changes.<\/p>\n<p><strong>New Medical Policies (Effective 12\/1\/2020)<\/strong><br \/>\nAzedra (iobenguane I 131)<br \/>\nNodify Lung Nodule Risk Assessment BDX-XL2 (Biodesix, Inc.)<\/p>\n<p><strong>New Medical Policy (Effective 1\/1\/2021)<\/strong><br \/>\nDeep Brain Stimulation Treatment for Essential Tremor and Parkinson\u2019s Disease<\/p>\n<p><strong>Reviewed and Updated (Effective 12\/1\/2020<\/strong><br \/>\n<strong>\u2022\u00a0<\/strong>Treatment of Lipodystrophy Syndrome (LDS)<br \/>\n\u2022 Updated Criteria for Approval &#8211; Added \u201cCommercial, Medicare, Medicaid\u201d to the section title<br \/>\n\u2022 HCPC Codes &#8211; Deleted Code C9800<br \/>\n\u2022 CPT Codes &#8211; Deleted Codes 15878 and 15879, as policy is for facial lipodystrophy<\/p>\n<p><strong>Surgical Management of Morbid Obesity<\/strong><br \/>\n\u2022 Updated Criteria for Approval:<br \/>\no Criteria for Approval for Ages 18 and Over<br \/>\no Criteria for Approval for Adolescents Ages 13-17<br \/>\no Repeat Bariatric Surgery<br \/>\no Medicare<br \/>\n\u2022 What is Not Covered<\/p>\n<p><strong>Contact Lenses<\/strong><br \/>\n\u2022 Updated Definitions, Scleral Shell or Shield &#8211; Added \u201cIt functions as a protective barrier against tear evaporation. Used as an artificial support and a protective covering for diseased eye or sightless or shrunken eye.\u201d<br \/>\n\u2022 Updated Criteria for Approval<\/p>\n<p><strong>Cochlear Implants, BAHA (Bone Anchored Hearing Aid), and ABI (Auditory Brainstem Implant)<\/strong><br \/>\n\u2022 Changed name of policy to add ABI<br \/>\n\u2022 Updated Definitions: Added description of hybrid cochlear implant<br \/>\n\u2022 Added HNE adopted InterQual criteria (where applicable)<br \/>\n\u2022 Updated headings in several sections:<br \/>\nFrom: \u201cAdult Criteria for Approval of Cochlear Implant for Commercial\/MassHealth\u201d<br \/>\nTo: \u201cCriteria for Approval of Cochlear Implant for All Lines of Business\u201d<\/p>\n<p>From: \u201cIV., Criteria for Approval of Hybrid Cochlear Implant\/Hearing Aid Devices that include hearing aid integration into the external sound processor of the cochlear implant when all of the<br \/>\nbelow criteria are met:\u201d<br \/>\nTo: \u201cII., Criteria for Approval of Hybrid Cochlear Implant\/Hearing Aid Devices (such as the Nuclear Hybrid L24 Cochlear Implant System) that include hearing aid integration into the external sound<br \/>\nprocessor of the cochlear implant when all the below criteria are met:\u201d<\/p>\n<p>From: \u201cVI., AUDITORY BRAINSTEM IMPLANT (ABI) is covered for:\u201d<br \/>\nTo: \u201cIV., Auditory Brainstem Implant (ABI), unilateral, is covered for\u201d<\/p>\n<p>\u2022 Updated What is Not Covered<br \/>\n\u2022 Updated HCPCS and Requirements<br \/>\no &#8220;Associated HCPCS that do not require PA\u201d Changed to \u201cAssociated HCPCS\u201d<br \/>\no Removed code L8613 (not configured for PA)<br \/>\no Added L8627, L8628, L8629 under cochlear devices (these codes have IQ criteria and are on config list)<br \/>\no Removed code L8691 (not configured for PA)<\/p>\n<p><strong>Abdominal Panniculectomy and Removal of Excess Skin<\/strong><br \/>\n\u2022 Changed name of policy to add \u201cand Removal of Excess Skin\u201d<br \/>\n\u2022 Updated Criteria for Approval: Commercial and Medicare<br \/>\n\u2022 Updated Criteria for Approval of MassHealth member \u2013 (Reviewed on a case-by-case basis)<br \/>\n\u2022 Updated CPT Codes: Added CPT codes in table form<\/p>\n<p><strong>Formula and Enteral Nutrition<\/strong><br \/>\n\u2022 Staff wanted clarification of policy as it technically was only for MassHealth &#8211; now LOB has been added<br \/>\n\u2022 Attached to policy is a link for Northwood&#8217;s criteria, which HNE will be using for MassHealth reviews<br \/>\n\u2022 Added Commercial criteria info, for use with all Commercial policies<br \/>\n\u2022 Added Medicare link for Medicare members<\/p>\n<p><strong>Intacs Corneal Implants (Intrastromal Corneal Ring Segments<\/strong><br \/>\n\u2022 Updated Criteria for Approval<br \/>\n\u2022 Updated What is Not Covered<\/p>\n<p><strong>Endothelial Keratoplasty (also known as Posterior Lamellar Keratoplasty)<\/strong><br \/>\n\u2022 Health New England has adopted InterQual criteria<br \/>\n\u2022 HNE Nurse Reviewers use InterQual through Medecision\u2019s Aerial Medical Management System<\/p>\n<p><strong>Percutaneous Left Atrial Appendage Closure<\/strong><br \/>\n\u2022 Updated Criteria for Approval<br \/>\n\u2022 Updated What is Not Covered<\/p>\n<p><strong>Balloon Sinus Dilation of the Eustachian Tubes<\/strong><br \/>\n\u2022 Code Correction &#8211; HCPC Code should be C9745 (NOT C7945)<\/p>\n<p><strong>Long-Term 30-Day Cardiac Monitoring<\/strong><br \/>\n\u2022 CPT Codes now included &#8211; 93228 which requires PA; and 93229 which does not require PA<\/p>\n<p><strong>Therapeutic Shoe and Orthotic Coverage<\/strong><br \/>\n\u2022 HCPCS codes added to policy<\/p>\n<p><strong>Orthognathic Surgery<\/strong><br \/>\n\u2022 CPT codes added to policy<\/p>\n<p><strong>Rhinoplasty<\/strong><br \/>\n\u2022 CPT codes added to policy<\/p>\n<p><strong>Reconstructive Repair of Pectus Excavatum or Pectus Carinatum<\/strong><br \/>\n\u2022 CPT codes added to policy<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Health New England\u2019s Clinical Policies have been updated and can be found at healthnewengland.org\/Providers\/Resources. Once on the Resources page, click on Behavioral Health\/Medical Policies to learn of the changes. New Medical Policies (Effective 12\/1\/2020) Azedra (iobenguane I 131) Nodify Lung Nodule Risk Assessment BDX-XL2 (Biodesix, Inc.) New Medical Policy (Effective 1\/1\/2021) Deep Brain Stimulation Treatment [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[92],"tags":[],"class_list":["post-5758","post","type-post","status-publish","format-standard","hentry","category-provider-newsletter"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6ZZHB-1uS","_links":{"self":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/5758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/comments?post=5758"}],"version-history":[{"count":1,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/5758\/revisions"}],"predecessor-version":[{"id":5759,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/5758\/revisions\/5759"}],"wp:attachment":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/media?parent=5758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/categories?post=5758"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/tags?post=5758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}